Pharmacy-focused quick commerce startup Plazza has secured $15 million in a Series A funding round co-led by Accel, Elevation Capital, and Nexus Venture Partners. The Bengaluru-based company, which aims to revolutionize medicine availability with its technology-driven platform, plans to use the fresh capital to enhance its tech capabilities, improve its AI-driven inventory management, and expand its pharmacy network to new regions. This significant investment underscores the growing interest in the quick commerce sector, especially in the healthcare domain, as consumers increasingly demand faster and more reliable services.
### Plazza’s Innovative Approach
Founded in 2024 by Aman Priyadarshi, Plazza operates a unique pharmacy-first quick commerce platform. It focuses on ensuring the availability of medicines through advanced AI-powered inventory systems, promising delivery times of 15 to 30 minutes. The company differentiates itself by maintaining a robust inventory, with each Plazza store stocking over 40,000 stock-keeping units (SKUs), which is significantly higher than the approximately 5,000 SKUs typically found in neighborhood pharmacies. This extensive inventory enables Plazza to achieve prescription fill rates of over 95%, far surpassing the industry average of 50% to 60%.
The startup’s growth metrics are promising, with its gross merchandise value (GMV) reportedly increasing nearly 27 times between June 2025 and March 2026. Furthermore, Plazza claims that its repeat customers tend to place orders with basket sizes approximately 30% larger than those of first-time users, indicating strong customer satisfaction and loyalty.
### Competitive Landscape and Funding Environment
Plazza’s latest funding round comes amid a fiercely competitive quick medicine delivery market in India. Major players such as Flipkart, Zepto, and Blinkit have also ventured into this space, underscoring the sector’s potential. Flipkart launched its medicine delivery service, Flipkart Minutes, in December 2024, while Zepto introduced its pharmacy service in 2025, offering 10-minute delivery in select cities. Blinkit has extended its offerings beyond over-the-counter medicines, piloting prescription medicine delivery in Bengaluru.
Investor interest in the sector remains robust. For instance, PlatinumRx, another Bengaluru-based online pharmacy, raised $6 million in September 2025, and Truemeds secured $85 million to bolster its presence in the online pharmacy market. This influx of funds highlights the confidence investors have in the sector’s growth potential, driven by increasing consumer demand for quick and efficient healthcare solutions.
### Implications for India’s Startup Ecosystem
The success of Plazza and similar startups reflects the dynamic nature of India’s startup ecosystem, where innovation and technology are rapidly transforming traditional sectors. The quick commerce model, especially in the healthcare domain, is gaining traction as it addresses critical gaps in accessibility and convenience. As Plazza expands its footprint, it could potentially set new benchmarks for service delivery in the pharmaceutical retail market.
For entrepreneurs and investors, Plazza’s growth story offers valuable insights into the opportunities and challenges of operating in India’s burgeoning quick commerce sector. As the company continues to scale, it may influence other startups to explore technology-driven solutions for other verticals within the healthcare industry.
As Plazza leverages its new funding to enhance its technology and expand its reach, industry stakeholders will be keenly watching how it navigates the intensifying competition. The next phase of Plazza’s journey will likely involve strategic partnerships and further innovations to maintain its competitive edge, making it a key player to watch in the coming months.